Form 8-K Silexion Therapeutics For: Aug 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Silexion Therapeutics faces Nasdaq delisting over equity shortfall
August 21, 2026 4:23 PM EDTSilexion Therapeutics Corp (NASDAQ: SLXN) received a delisting notice from the Nasdaq Listing Qualifications Department on August 18, 2026, for failing to meet the minimum shareholders' equity requirement for continued listing on The Nasdaq Capital Market.
The notice relates to non-compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed under the Equity Standard to maintain at least $2,500,000 in... More
